genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
DNA
X and Y: Synthorx Expands the Genetic Code to Create Optimized…
Cancer
Set Phase Separation to Stun
Gene Therapy
A New Vision for Gene Therapy
OMICs
Can Encodia Become the Illumina of Proteomics?
Alzheimers
Cognition Thinks It Has an Alzheimer’s Blockbuster
News
Coronavirus
Lung Meds Delivered by Neutrophil-Derived Nanovesicles
Cancer
Lung Cancer Sees New Drug Targets Get “Ironed Out”
Epigenetics
Epigenetic Reset Reverses Age- and Glaucoma Damage-Related Vision Loss in Mice
News
Portable NMR Sensor Detects Fatty Liver Disease and Fibrosis in Mice
CRISPR-Cas9
CRISPR Screening IDs Factors for Turning Stem Cells into Neurons
Insights
All
Trends for 2020
Women in Life Science
Doudna Talks Nobel Success and Women in Science
OMICs
Genomics Analysis Moves to the Next Level
December 2020 Vol. 40 No. 12
Viral Clearance in the Manufacture of Biologics
December 2020 Vol. 40 No. 12
Viral Testing in the Era of Continuous Biomanufacturing and COVID-19
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Coronavirus
Lung Meds Delivered by Neutrophil-Derived Nanovesicles
Women in Life Science
Doudna Talks Nobel Success and Women in Science
Cancer
Lung Cancer Sees New Drug Targets Get “Ironed Out”
Epigenetics
Epigenetic Reset Reverses Age- and Glaucoma Damage-Related Vision Loss in Mice
Magazine
All
Supplement
November 2020 Vol. 40 No. 11
With Synthetic Biology Nature Is All Business
Biobanking
Biobanks Are Becoming Data Banks in the Era of Personalized Medicine
Biobanking
Cryopreservation to Improve Cell Manufacturing and Biobanking
Biobanking
Enabling Scientific Discovery and Healthcare with Biobanks
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
RNA
miRNA
miRNA
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
miRNA
Mirna Initiates PI Trial for miRNA Candidate Cancer Drug
miRNA
AstraZeneca Partners on miRNA Inhibitors
miRNA
miRNA: The Key to Losing Those Love Handles?
miRNA
Investigators Identify Two miRNAs Involved in Regulating Insulin Sensitivity
miRNA
Scientists Use miRNAs to Improve Efficiency of Generating iPSCs Without Transcription Factors
miRNA
Pregnancy Obesity Alters Fetal Liver Epigenetics and Metabolic Pathways
miRNA
Anticancer miRNA Coupled to Folate Needs No Protective Packaging
miRNA
Melanoma Opens Metastatic Attack with MicroRNA Barrage
miRNA
Scientists Find miRNA Involved in Obesity-Induced Insulin Resistance
miRNA
Integrated DNA Technologies to Custom Manufacture Quanta Biosciences’ miRNA Assays
miRNA
MiRagen Pockets $20M to Further miRNA-Based Drugs
miRNA
Exiqon Expands Portfolio with Norgen’s RNA Purification Kits
miRNA
SINGLE miRNA MOLECULE CONTROLS BLOOD VESSEL DEVELOPMENT
miRNA
Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics
miRNA
Regulus and UCSD Partner to Develop miRNA-Targeting Anti-Angiogenesis Therapeutics
1
2
3
...
13
Page 1 of 13
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Collaboration gives Servier ex-U.S./Japan global rights to three of Miragen’s preclinical programs.[© Dario Bajurin - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Oct18_2011_3203632_BloodVessels_ServierMiragenCardioDeal1671558221-324x160.jpg "Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics")
![University grant-funded collaboration will exploit Regulus miRNA platform with UCSD’s expertise in angiogenesis models.[© Dario Bajurin - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/April14_2011_3203632_BloodVessels_RegulusUCSDmiRNAAngiogenesis1401452201-324x160.jpg "Regulus and UCSD Partner to Develop miRNA-Targeting Anti-Angiogenesis Therapeutics")
